Researchers from the University of Pittsburgh School of Medicine have demonstrated for the first time that gene therapy can reverse diabetic neuropathy. While their studies have so far only involved mice, the results are significant because they provide the earliest evidence that such an approach might some day help people with diabetes, in whom neuropathy is a common complication that causes irreversible nerve damage. Details of the research were presented today at the 34th Annual Meeting of the Society for Neuroscience, being held Oct. 23 – 27 in San Diego.
